U.K. tallies losses on pandemic vaccine

U.K. officials say they essentially lost more than £200 million ($308.9 million) buying up excess quantities of swine flu vaccine and antiviral meds. About a third of that loss occurred because unused vaccines weren't stored properly. And there's no secondary market for their surplus. "The worldwide surplus of swine flu vaccine means that there is no active market in which the department's excess pandemic flu inventory can be sold," health officials report. Story

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

With COVID vaccinations expected to start in the coming weeks, 2021 is shaping up to be quite a year for the companies with leading vaccines.

The U.K. became the first Western country to authorize a COVID-19 vaccine, making the Pfizer/BioNTech shot the first mRNA vaccine for widespread use.